eGleams - Update from Catalyst for a Cure

Your July Newsletter from Glaucoma Research Foundation.

July 2017 Dear Tushar, Key to helping prevent irrevocable vision loss from glaucoma is early detection combined with effective treatment. But to date, mechanisms to evaluate the progression of glaucoma have been limited. Now investigators with the Catalyst for a Cure (CFC) Biomarker Initiative are on the verge of upending this barrier through the identification of new biological markers for glaucoma. Biomarkers can provide physicians with better tools to diagnose and manage glaucoma before vision is lost, as well as accelerate the pace of discovery toward better treatments and ultimately a cure for glaucoma. Thanks to the CFC Biomarker Initiative, identification of molecular biomarkers for glaucoma has greatly accelerated. The CFC investigators have made extraordinary progress in speeding the progress of investigation, and they are now at a critical tipping point. With the aid of the diagnostic tools they created, the researchers have identified biomarkers that may be among the earliest to show changes in glaucoma. Functional tests for these new biomarkers have been validated in models of glaucoma and are now being tested in patients. "Our ability to bridge from laboratory studies to human studies, and now take that into the clinic, is what we set out to do six years ago," says CFC principal investigator Andrew Huberman, PhD. Read the full article on our website... Video: Curing Blindness is "A Call to Arms" Andrew D. Huberman, PhD, Associate Professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine, discsuses what motivates him as a scientist seeking a cure for blindness. Video: Update on Optic Nerve Regeneration  Larry Benowitz, PhD (Professor of Surgery and Ophthalmology, Boston Children's Hospital, Harvard Medical School) discusses how far the field of optic nerve regeneration has come in the past 10 years. Related Articles Restoring Vision: Retinal Nerve Cell Regeneration Working Together to Find Biomarkers for Glaucoma Means Lower Risk of Vision Loss  Glaucoma Research Foundation Launches The Cure is in Sight Campaign to Raise $15 Million for Research and Education www.glaucoma.org

Share this email: Manage your preferences | Opt out using TrueRemove™ Got this as a forward? Sign up to receive our future emails. View this email online. 251 Post St Ste 600 San Francisco, CA | 94108 US This email was sent to bestsmmservice.huha@blogger.com. To continue receiving our emails, add us to your address book.